ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Venous Thromboembolism Treatment Options Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-38X10315
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Venous Thromboembolism Treatment Options Market Research Report 2022
BUY CHAPTERS

Global Venous Thromboembolism Treatment Options Market Research Report 2025

Code: QYRE-Auto-38X10315
Report
February 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AngioDynamics
Cardinal Health Inc.
BTG International Ltd
Stryker Corporation
DJO Global Inc.
Janssen Pharmaceuticals, Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.

Venous Thromboembolism Treatment Options Market Size

The global market for Venous Thromboembolism Treatment Options was valued at US$ 389 million in the year 2024 and is projected to reach a revised size of US$ 493 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Venous Thromboembolism Treatment Options Market

Venous Thromboembolism Treatment Options Market

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood"s ability to clot. They don"t break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Treatment Options, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Treatment Options.
The Venous Thromboembolism Treatment Options market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Venous Thromboembolism Treatment Options market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Thromboembolism Treatment Options manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Venous Thromboembolism Treatment Options Market Report

Report Metric Details
Report Name Venous Thromboembolism Treatment Options Market
Accounted market size in year US$ 389 million
Forecasted market size in 2031 US$ 493 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp., Janssen Pharmaceuticals, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Venous Thromboembolism Treatment Options manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Venous Thromboembolism Treatment Options in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Venous Thromboembolism Treatment Options Market growing?

Ans: The Venous Thromboembolism Treatment Options Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Venous Thromboembolism Treatment Options Market size in 2031?

Ans: The Venous Thromboembolism Treatment Options Market size in 2031 will be US$ 493 million.

Who are the main players in the Venous Thromboembolism Treatment Options Market report?

Ans: The main players in the Venous Thromboembolism Treatment Options Market are AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp., Janssen Pharmaceuticals, Inc

What are the Application segmentation covered in the Venous Thromboembolism Treatment Options Market report?

Ans: The Applications covered in the Venous Thromboembolism Treatment Options Market report are Hospitals, Catheterisation Laboratories, Ambulatory Surgical Centers

What are the Type segmentation covered in the Venous Thromboembolism Treatment Options Market report?

Ans: The Types covered in the Venous Thromboembolism Treatment Options Market report are Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Others

Recommended Reports

VTE & Thrombosis

Anticoagulants & Blood Therapy

Cardiovascular Devices & Therapy

1 Venous Thromboembolism Treatment Options Market Overview
1.1 Product Definition
1.2 Venous Thromboembolism Treatment Options by Type
1.2.1 Global Venous Thromboembolism Treatment Options Market Value Comparison by Type (2024 VS 2031)
1.2.2 Upper Pneumatic Compression Sleeves
1.2.3 Lower Pneumatic Compression Sleeves
1.2.4 Permanent Inferior Vena Cava Filters
1.2.5 Others
1.3 Venous Thromboembolism Treatment Options by Application
1.3.1 Global Venous Thromboembolism Treatment Options Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Catheterisation Laboratories
1.3.4 Ambulatory Surgical Centers
1.4 Global Venous Thromboembolism Treatment Options Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism Treatment Options Revenue 2020-2031
1.4.2 Global Venous Thromboembolism Treatment Options Sales 2020-2031
1.4.3 Global Venous Thromboembolism Treatment Options Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Venous Thromboembolism Treatment Options Market Competition by Manufacturers
2.1 Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturers (2020-2025)
2.2 Global Venous Thromboembolism Treatment Options Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Venous Thromboembolism Treatment Options Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Venous Thromboembolism Treatment Options, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Venous Thromboembolism Treatment Options, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Venous Thromboembolism Treatment Options, Product Type & Application
2.7 Global Key Manufacturers of Venous Thromboembolism Treatment Options, Date of Enter into This Industry
2.8 Global Venous Thromboembolism Treatment Options Market Competitive Situation and Trends
2.8.1 Global Venous Thromboembolism Treatment Options Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Venous Thromboembolism Treatment Options Players Market Share by Revenue
2.8.3 Global Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Venous Thromboembolism Treatment Options Market Scenario by Region
3.1 Global Venous Thromboembolism Treatment Options Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Venous Thromboembolism Treatment Options Sales by Region: 2020-2031
3.2.1 Global Venous Thromboembolism Treatment Options Sales by Region: 2020-2025
3.2.2 Global Venous Thromboembolism Treatment Options Sales by Region: 2026-2031
3.3 Global Venous Thromboembolism Treatment Options Revenue by Region: 2020-2031
3.3.1 Global Venous Thromboembolism Treatment Options Revenue by Region: 2020-2025
3.3.2 Global Venous Thromboembolism Treatment Options Revenue by Region: 2026-2031
3.4 North America Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.4.1 North America Venous Thromboembolism Treatment Options Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Venous Thromboembolism Treatment Options Sales by Country (2020-2031)
3.4.3 North America Venous Thromboembolism Treatment Options Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.5.1 Europe Venous Thromboembolism Treatment Options Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Venous Thromboembolism Treatment Options Sales by Country (2020-2031)
3.5.3 Europe Venous Thromboembolism Treatment Options Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Venous Thromboembolism Treatment Options Market Facts & Figures by Region
3.6.1 Asia Pacific Venous Thromboembolism Treatment Options Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2020-2031)
3.6.3 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.7.1 Latin America Venous Thromboembolism Treatment Options Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Venous Thromboembolism Treatment Options Sales by Country (2020-2031)
3.7.3 Latin America Venous Thromboembolism Treatment Options Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.8.1 Middle East and Africa Venous Thromboembolism Treatment Options Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2020-2031)
3.8.3 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Venous Thromboembolism Treatment Options Sales by Type (2020-2031)
4.1.1 Global Venous Thromboembolism Treatment Options Sales by Type (2020-2025)
4.1.2 Global Venous Thromboembolism Treatment Options Sales by Type (2026-2031)
4.1.3 Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2020-2031)
4.2 Global Venous Thromboembolism Treatment Options Revenue by Type (2020-2031)
4.2.1 Global Venous Thromboembolism Treatment Options Revenue by Type (2020-2025)
4.2.2 Global Venous Thromboembolism Treatment Options Revenue by Type (2026-2031)
4.2.3 Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2020-2031)
4.3 Global Venous Thromboembolism Treatment Options Price by Type (2020-2031)
5 Segment by Application
5.1 Global Venous Thromboembolism Treatment Options Sales by Application (2020-2031)
5.1.1 Global Venous Thromboembolism Treatment Options Sales by Application (2020-2025)
5.1.2 Global Venous Thromboembolism Treatment Options Sales by Application (2026-2031)
5.1.3 Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2020-2031)
5.2 Global Venous Thromboembolism Treatment Options Revenue by Application (2020-2031)
5.2.1 Global Venous Thromboembolism Treatment Options Revenue by Application (2020-2025)
5.2.2 Global Venous Thromboembolism Treatment Options Revenue by Application (2026-2031)
5.2.3 Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2020-2031)
5.3 Global Venous Thromboembolism Treatment Options Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AngioDynamics
6.1.1 AngioDynamics Company Information
6.1.2 AngioDynamics Description and Business Overview
6.1.3 AngioDynamics Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AngioDynamics Venous Thromboembolism Treatment Options Product Portfolio
6.1.5 AngioDynamics Recent Developments/Updates
6.2 Cardinal Health Inc.
6.2.1 Cardinal Health Inc. Company Information
6.2.2 Cardinal Health Inc. Description and Business Overview
6.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Portfolio
6.2.5 Cardinal Health Inc. Recent Developments/Updates
6.3 BTG International Ltd.
6.3.1 BTG International Ltd. Company Information
6.3.2 BTG International Ltd. Description and Business Overview
6.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Product Portfolio
6.3.5 BTG International Ltd. Recent Developments/Updates
6.4 Stryker Corporation
6.4.1 Stryker Corporation Company Information
6.4.2 Stryker Corporation Description and Business Overview
6.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Product Portfolio
6.4.5 Stryker Corporation Recent Developments/Updates
6.5 DJO Global Inc.
6.5.1 DJO Global Inc. Company Information
6.5.2 DJO Global Inc. Description and Business Overview
6.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Product Portfolio
6.5.5 DJO Global Inc. Recent Developments/Updates
6.6 EKOS Corp
6.6.1 EKOS Corp Company Information
6.6.2 EKOS Corp Description and Business Overview
6.6.3 EKOS Corp Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.6.4 EKOS Corp Venous Thromboembolism Treatment Options Product Portfolio
6.6.5 EKOS Corp Recent Developments/Updates
6.7 Teleflex Inc., Boston Scientific Corp.
6.7.1 Teleflex Inc., Boston Scientific Corp. Company Information
6.7.2 Teleflex Inc., Boston Scientific Corp. Description and Business Overview
6.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Portfolio
6.7.5 Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
6.8 Janssen Pharmaceuticals, Inc
6.8.1 Janssen Pharmaceuticals, Inc Company Information
6.8.2 Janssen Pharmaceuticals, Inc Description and Business Overview
6.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Portfolio
6.8.5 Janssen Pharmaceuticals, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Venous Thromboembolism Treatment Options Industry Chain Analysis
7.2 Venous Thromboembolism Treatment Options Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Venous Thromboembolism Treatment Options Production Mode & Process Analysis
7.4 Venous Thromboembolism Treatment Options Sales and Marketing
7.4.1 Venous Thromboembolism Treatment Options Sales Channels
7.4.2 Venous Thromboembolism Treatment Options Distributors
7.5 Venous Thromboembolism Treatment Options Customer Analysis
8 Venous Thromboembolism Treatment Options Market Dynamics
8.1 Venous Thromboembolism Treatment Options Industry Trends
8.2 Venous Thromboembolism Treatment Options Market Drivers
8.3 Venous Thromboembolism Treatment Options Market Challenges
8.4 Venous Thromboembolism Treatment Options Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AngioDynamics
Cardinal Health Inc.
BTG International Ltd
Stryker Corporation
DJO Global Inc.
Janssen Pharmaceuticals, Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
List of Tables
 Table 1. Global Venous Thromboembolism Treatment Options Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Venous Thromboembolism Treatment Options Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Venous Thromboembolism Treatment Options Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Venous Thromboembolism Treatment Options Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Venous Thromboembolism Treatment Options Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Venous Thromboembolism Treatment Options Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Venous Thromboembolism Treatment Options Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Venous Thromboembolism Treatment Options, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Venous Thromboembolism Treatment Options, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Venous Thromboembolism Treatment Options, Product Type & Application
 Table 12. Global Key Manufacturers of Venous Thromboembolism Treatment Options, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Venous Thromboembolism Treatment Options by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Treatment Options as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Venous Thromboembolism Treatment Options Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Venous Thromboembolism Treatment Options Sales by Region (2020-2025) & (K Units)
 Table 18. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2020-2025)
 Table 19. Global Venous Thromboembolism Treatment Options Sales by Region (2026-2031) & (K Units)
 Table 20. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2026-2031)
 Table 21. Global Venous Thromboembolism Treatment Options Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2020-2025)
 Table 23. Global Venous Thromboembolism Treatment Options Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2026-2031)
 Table 25. North America Venous Thromboembolism Treatment Options Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Venous Thromboembolism Treatment Options Sales by Country (2020-2025) & (K Units)
 Table 27. North America Venous Thromboembolism Treatment Options Sales by Country (2026-2031) & (K Units)
 Table 28. North America Venous Thromboembolism Treatment Options Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Venous Thromboembolism Treatment Options Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Venous Thromboembolism Treatment Options Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Venous Thromboembolism Treatment Options Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Venous Thromboembolism Treatment Options Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Venous Thromboembolism Treatment Options Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Venous Thromboembolism Treatment Options Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Venous Thromboembolism Treatment Options Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Venous Thromboembolism Treatment Options Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Venous Thromboembolism Treatment Options Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Venous Thromboembolism Treatment Options Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Venous Thromboembolism Treatment Options Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Venous Thromboembolism Treatment Options Sales (K Units) by Type (2020-2025)
 Table 51. Global Venous Thromboembolism Treatment Options Sales (K Units) by Type (2026-2031)
 Table 52. Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2020-2025)
 Table 53. Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2026-2031)
 Table 54. Global Venous Thromboembolism Treatment Options Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Venous Thromboembolism Treatment Options Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2020-2025)
 Table 57. Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2026-2031)
 Table 58. Global Venous Thromboembolism Treatment Options Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Venous Thromboembolism Treatment Options Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Venous Thromboembolism Treatment Options Sales (K Units) by Application (2020-2025)
 Table 61. Global Venous Thromboembolism Treatment Options Sales (K Units) by Application (2026-2031)
 Table 62. Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2020-2025)
 Table 63. Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2026-2031)
 Table 64. Global Venous Thromboembolism Treatment Options Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Venous Thromboembolism Treatment Options Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2020-2025)
 Table 67. Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2026-2031)
 Table 68. Global Venous Thromboembolism Treatment Options Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Venous Thromboembolism Treatment Options Price (US$/Unit) by Application (2026-2031)
 Table 70. AngioDynamics Company Information
 Table 71. AngioDynamics Description and Business Overview
 Table 72. AngioDynamics Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AngioDynamics Venous Thromboembolism Treatment Options Product
 Table 74. AngioDynamics Recent Developments/Updates
 Table 75. Cardinal Health Inc. Company Information
 Table 76. Cardinal Health Inc. Description and Business Overview
 Table 77. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product
 Table 79. Cardinal Health Inc. Recent Developments/Updates
 Table 80. BTG International Ltd. Company Information
 Table 81. BTG International Ltd. Description and Business Overview
 Table 82. BTG International Ltd. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BTG International Ltd. Venous Thromboembolism Treatment Options Product
 Table 84. BTG International Ltd. Recent Developments/Updates
 Table 85. Stryker Corporation Company Information
 Table 86. Stryker Corporation Description and Business Overview
 Table 87. Stryker Corporation Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Stryker Corporation Venous Thromboembolism Treatment Options Product
 Table 89. Stryker Corporation Recent Developments/Updates
 Table 90. DJO Global Inc. Company Information
 Table 91. DJO Global Inc. Description and Business Overview
 Table 92. DJO Global Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. DJO Global Inc. Venous Thromboembolism Treatment Options Product
 Table 94. DJO Global Inc. Recent Developments/Updates
 Table 95. EKOS Corp Company Information
 Table 96. EKOS Corp Description and Business Overview
 Table 97. EKOS Corp Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. EKOS Corp Venous Thromboembolism Treatment Options Product
 Table 99. EKOS Corp Recent Developments/Updates
 Table 100. Teleflex Inc., Boston Scientific Corp. Company Information
 Table 101. Teleflex Inc., Boston Scientific Corp. Description and Business Overview
 Table 102. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product
 Table 104. Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
 Table 105. Janssen Pharmaceuticals, Inc Company Information
 Table 106. Janssen Pharmaceuticals, Inc Description and Business Overview
 Table 107. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product
 Table 109. Janssen Pharmaceuticals, Inc Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Venous Thromboembolism Treatment Options Distributors List
 Table 113. Venous Thromboembolism Treatment Options Customers List
 Table 114. Venous Thromboembolism Treatment Options Market Trends
 Table 115. Venous Thromboembolism Treatment Options Market Drivers
 Table 116. Venous Thromboembolism Treatment Options Market Challenges
 Table 117. Venous Thromboembolism Treatment Options Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Venous Thromboembolism Treatment Options
 Figure 2. Global Venous Thromboembolism Treatment Options Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Venous Thromboembolism Treatment Options Market Share by Type: 2024 & 2031
 Figure 4. Upper Pneumatic Compression Sleeves Product Picture
 Figure 5. Lower Pneumatic Compression Sleeves Product Picture
 Figure 6. Permanent Inferior Vena Cava Filters Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Venous Thromboembolism Treatment Options Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Venous Thromboembolism Treatment Options Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Catheterisation Laboratories
 Figure 12. Ambulatory Surgical Centers
 Figure 13. Global Venous Thromboembolism Treatment Options Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Venous Thromboembolism Treatment Options Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Venous Thromboembolism Treatment Options Sales (2020-2031) & (K Units)
 Figure 16. Global Venous Thromboembolism Treatment Options Average Price (US$/Unit) & (2020-2031)
 Figure 17. Venous Thromboembolism Treatment Options Report Years Considered
 Figure 18. Venous Thromboembolism Treatment Options Sales Share by Manufacturers in 2024
 Figure 19. Global Venous Thromboembolism Treatment Options Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Venous Thromboembolism Treatment Options Players: Market Share by Revenue in Venous Thromboembolism Treatment Options in 2024
 Figure 21. Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Venous Thromboembolism Treatment Options Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Venous Thromboembolism Treatment Options Sales Market Share by Country (2020-2031)
 Figure 24. North America Venous Thromboembolism Treatment Options Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Venous Thromboembolism Treatment Options Sales Market Share by Country (2020-2031)
 Figure 28. Europe Venous Thromboembolism Treatment Options Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Venous Thromboembolism Treatment Options Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Venous Thromboembolism Treatment Options Revenue Market Share by Region (2020-2031)
 Figure 36. China Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Venous Thromboembolism Treatment Options Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Venous Thromboembolism Treatment Options Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Venous Thromboembolism Treatment Options Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Venous Thromboembolism Treatment Options Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Venous Thromboembolism Treatment Options by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Venous Thromboembolism Treatment Options by Type (2020-2031)
 Figure 58. Global Venous Thromboembolism Treatment Options Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Venous Thromboembolism Treatment Options by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Venous Thromboembolism Treatment Options by Application (2020-2031)
 Figure 61. Global Venous Thromboembolism Treatment Options Price (US$/Unit) by Application (2020-2031)
 Figure 62. Venous Thromboembolism Treatment Options Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Venous Thromboembolism Therapy Market Research Report 2025
Global Thrombosis Drug Market Research Report 2025
Global Injectable Blood Thinners Market Research Report 2025
Global Venous Thromboembolism Prophylaxis Market Research Report 2025
Venous Thromboembolism Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anticoagulant Treatment Market Insights Forecast to 2030
Global Anticoagulant Medicines Market Research Report 2025
Global Antithrombotic Treatment Market Insights Forecast to 2030
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Enoxaparin Sodium Market Research Report 2024
Deep Vein Thrombosis DVT Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antithrombotic Pump Market Research Report 2025
Global Intravenous Anticoagulants Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Deep Vein Thrombosis DVT Pumps Market Insights Forecast to 2030
Hypercoagulation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Deep Vein Thrombosis Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anticoagulants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Factor Xa Inhibitors Market Research Report 2024
Global Venous Thromboembolism Therapeutics Market Research Report 2025

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions